3-98168985-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001005515.2(OR5H15):āc.286G>Cā(p.Glu96Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000026 in 1,613,498 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001005515.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OR5H15 | NM_001005515.2 | c.286G>C | p.Glu96Gln | missense_variant | 2/2 | ENST00000641450.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OR5H15 | ENST00000641450.1 | c.286G>C | p.Glu96Gln | missense_variant | 2/2 | NM_001005515.2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 151950Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000104 AC: 26AN: 250764Hom.: 0 AF XY: 0.0000885 AC XY: 12AN XY: 135528
GnomAD4 exome AF: 0.0000260 AC: 38AN: 1461428Hom.: 0 Cov.: 35 AF XY: 0.0000248 AC XY: 18AN XY: 727036
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152070Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74324
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 19, 2023 | The c.286G>C (p.E96Q) alteration is located in exon 1 (coding exon 1) of the OR5H15 gene. This alteration results from a G to C substitution at nucleotide position 286, causing the glutamic acid (E) at amino acid position 96 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at